Brain Injuries, AcutePIReNCT07590726
PIRe 2.0: A Stepped-Care Model for Involving Relatives Across Sectors
A study testing Supportive Care in people with Brain Injuries, Acute and Brain Tumor Adult, run by Copenhagen University Hospital, Rigshospitalet at 1 site in Denmark.
Trial summary
Serious brain diseases and injuries affect not only the person who becomes ill or injured, but also their family. Relatives of people with acquired brain injury (ABI) or malignant brain tumor (MBT) often take on a major role in daily care, decision-making, and coordination across healthcare services. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Brain Injuries, Acute, Brain Tumor Adult, Brain (Nervous System) Cancers
- What is being tested?
- Supportive Care
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 160 participants
- Where
- 1 siteDenmark
- Study dates
- 1 Oct 2026to 30 Sep 2029
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Primary relative of an adult diagnosed with acquired brain injury (ABI) or malignant brain tumor (MBT), admitted to a participating hospital department.
- Formally identified as the primary relative by the patient.
- Aged ≥18 years.
- Ability to read, understand, and complete questionnaires in Danish.
Who cannot join
- Insufficient proficiency in Danish to complete questionnaires and participate in structured conversations.
- Concurrent participation in another interventional study with a similar aim that may interfere with the present study.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Denmark1 site
Rigshospitalet
Copenhagen, Ø, 2100
Rikke Guldager Guldager, PhD, 0045 51199727, rikke.guldager.01@regionh.dk
Ingrid Poulsen, Professor, 004541277383, ingrid.poulsen@regionh.dk
About this study
Serious brain diseases and injuries affect not only the person who becomes ill or injured, but also their family. Relatives of people with acquired brain injury (ABI) or malignant brain tumor (MBT) often take on a major role in daily care, decision-making, and coordination across healthcare services. This role can include managing information, supporting rehabilitation, and acting as a link between hospital care and community rehabilitation. Many relatives report high levels of stress, uncertainty, and emotional burden, especially during transitions between care settings.
Despite recommendations for greater involvement of relatives, support for this group is often uneven and poorly coordinated across healthcare sectors. Relatives frequently experience lack of overview, limited guidance, and unclear expectations regarding their role. These challenges may increase caregiver burden and negatively affect both relatives' well-being and the continuity of care.
Read more
The PIRe 2.0 study aims to further test, and implement a structured intervention to support systematic involvement of relatives of people with ABI or MBT across hospital and community rehabilitation services. The intervention is designed as a "caregiver compass" that helps relatives understand their role, clarify their needs and wishes for involvement, and gain better overview of the care pathway.
PIRe 2.0 is delivered through a stepped-care model, which allows the level of support to be adjusted over time based on each relative's level of burden and support needs. All relatives receive basic information and screening for caregiver burden using the 4-item Zarit Burden Interview (ZBI-4). Relatives who show signs of increased burden are offered additional support in steps, ranging from structured conversations with nurses to extended cross-sector coordination and specialized support for relatives with high or complex needs. Decisions about stepping up or down are based on both screening results and clinical assessment to ensure flexibility and person-centered care.
The study includes two groups of relatives: an intervention group receiving support through the PIRe stepped-care model, and a control group receiving usual care only. A total of 160 relatives will participate. Data are collected at baseline, at transitions between hospital and community care, and three to six months after the intervention.
The primary outcome is change in caregiver burden, measured with the Caregiver Burden Scale (CBS). Secondary outcomes include relatives' roles and responsibilities, perceived support and involvement in care, and mental well-being, assessed using validated patient-reported outcome measures.
In addition to evaluating the effect of the intervention, the study examines how the PIRe model can be implemented and sustained in everyday practice across healthcare sectors. The results are expected to show whether a structured, stepped-care approach can reduce caregiver burden, improve coordination between hospital and community services, and support more coherent and secure care pathways for people with ABI or malignant brain tumor and their relatives.
Read the detailed description
Relatives of people with acquired brain injury (ABI) or malignant brain tumor (MBT, World Health Organization grade 3-4) play a central role in supporting patients throughout complex neurological care pathways. Both patient groups are characterized by multifaceted disease trajectories and substantial needs for coordination and support within the healthcare system. These demands are often associated with high caregiver burden among relatives. While ABI trajectories typically involve prolonged rehabilitation and long-term functional impairments, MBT is more often characterized by an acute, progressive, and life-threatening course. Despite these differences, relatives across both groups face considerable emotional, practical, and organizational challenges.
Even within well-developed healthcare systems, relatives continue to perform a large share of care and coordination tasks and frequently assume an informal caregiver role without sufficient professional support or clear coordination across sectors. This role is associated with increased risk of emotional distress, frustration, and reduced mental well-being. Although policies and guidelines recommend greater involvement of relatives, systematic and structured approaches to supporting relatives in clinical practice remain limited.
Transitions between hospital care and community-based rehabilitation represent a particularly vulnerable phase. Insufficient communication and lack of continuity across sectors are well-documented sources of burden for relatives. Studies show that breakdowns in communication during transitions increase the risk of uncertainty, misunderstandings, and experiences of exclusion. Relatives often describe acting as informal coordinators and intermediaries between healthcare sectors, a role that may substantially increase both practical and emotional strain, especially when expectations and responsibilities are unclear.
To address these challenges, the PIRe intervention was developed as a nurse-led, multicomponent approach aimed at strengthening early and meaningful involvement of relatives. The intervention combines structured conversations with relatives, diagnosis-specific information delivered in an accessible format (including digital access), and a peer-developed checklist to support navigation of the care pathway. Findings from a prior feasibility study demonstrated substantial variation in relatives' needs over time. Many relatives in the acute phase had limited capacity for intensive support, while the need for more targeted and sustained support often increased later in the disease trajectory. These findings highlighted the need for a systematic yet flexible organizational framework that can tailor support over time and ensure continuity across hospital and community settings.
A stepped-care approach provides an evidence-based framework for structuring support and involvement of relatives with the possibility of gradual escalation and de-escalation across sectors. PIRe 2.0 represents the next step as a real-world effectiveness and implementation study in which the PIRe intervention is delivered and evaluated as a scalable stepped-care model for systematic involvement of relatives in complex neurological care pathways.
The overall aim of the PIRe 2.0 study is to evaluate the effect of the PIRe intervention on caregiver burden among relatives of people with ABI or MBT when delivered through a stepped-care model. In parallel, the study aims to evaluate key implementation outcomes when the intervention is delivered across hospital departments and community rehabilitation services.
Design and Study Components PIRe 2.0 comprises two concurrent and complementary sub-studies. Both involve delivery of the PIRe intervention but serve different analytical purposes. Sub-study 1 evaluates the effectiveness of the intervention under real-world conditions, while Sub-study 2 focuses on the development, evaluation, and refinement of an implementation strategy and examines organizational embedding in hospital and municipal practice.
Stepped-Care Framework The stepped-care model constitutes the shared structural framework for both the effectiveness and implementation components. The model is centered on systematic screening and monitoring of caregiver burden using the 4-item Zarit Burden Interview (ZBI-4), a validated tool for identifying caregiver-related strain. Screening results, combined with clinical assessment, guide decisions regarding the appropriate level of support within the model.
ZBI-4 is applied across all steps of the model as both a screening and monitoring tool. Initial screening is conducted at the start of hospital admission, with repeated assessments during hospitalization, at sector transitions, and when clinical concern about changes in caregiver burden arises. Guideline-based threshold values are used to support decisions about escalating or de-escalating support while maintaining flexibility through clinical judgment. This approach is intended to ensure individualized and responsive care for relatives.
Recruitment and Study Population Relatives are recruited through convenience sampling from participating neurological, neurosurgical, and neurorehabilitation departments at collaborating hospitals. A total of 160 relatives are included, divided between an intervention group and a control group receiving usual care. A sequential inclusion design is used, where the control group is fully recruited and completed prior to initiation of the intervention group. This design minimizes risk of contamination and ensures that staff training and intervention implementation are completed before delivery of the intervention.
Data Collection and Analysis Data are collected at baseline, at transitions between hospital and community rehabilitation, and three to six months after intervention delivery. The study uses validated patient-reported outcome instruments to assess caregiver burden, roles and responsibilities, perceived support and involvement, and mental well-being. Electronic data collection is used throughout, with secure data management procedures in place.
Intervention effects are analyzed using linear mixed-effects regression models, allowing for evaluation of changes over time and accounting for repeated measurements. The primary outcome is change in caregiver burden, with secondary outcomes addressing functional roles, perceived support, and symptoms of anxiety and depression.
Implementation Evaluation The implementation component of PIRe 2.0 is guided by theory- and evidence-based frameworks and informed by experiences from the prior feasibility study. The implementation strategy is developed in close collaboration with clinical and municipal stakeholders and evaluated across multiple dimensions, including acceptability, appropriateness, feasibility, fidelity, penetration, and sustainability. The sequential study design facilitates stepwise testing and refinement of the implementation strategy prior to full-scale rollout in routine practice.
The implementation targets nurses in hospital departments and community rehabilitation services who are involved in care trajectories for patients with ABI or MBT and their relatives. Training, standardized manuals, and ongoing supervision are used to support consistent and high-quality delivery of the intervention.
Cross-Sector Collaboration and Context The study is anchored in close cross-sector collaboration between hospitals and municipal rehabilitation services and is conducted in both urban and rural settings. This allows evaluation of the intervention under varying organizational conditions and strengthens the generalizability of findings. The study is conducted during a period of significant structural healthcare reforms, requiring a high degree of flexibility to adapt to changing organizational contexts.
User and Public Involvement Relatives of people with ABI and MBT are involved through an advisory panel that contributes to refining intervention content, relevance, and interpretation of results. User involvement is documented systematically and embedded throughout the project to ensure alignment with relatives' needs and perspectives.
Ethics and Expected Impact The study is conducted in accordance with ethical principles and data protection regulations. Participation is voluntary, and data are handled confidentially.
PIRe 2.0 addresses a well-documented need for more systematic and coordinated involvement of relatives in complex neurological care pathways. By combining a stepped-care model with cross-sector collaboration, the study aims to reduce caregiver burden, strengthen continuity of care, and support sustainable implementation of a scalable model that can be integrated into routine clinical and municipal practice and adapted to other patient groups.
- Conditions
- Brain Injuries, Acute, Brain Tumor Adult, Brain (Nervous System) Cancers, Traumatic Brain Injuries, Glioblastom WHO Grade 4, Glioblastoma (GBM)
- Being tested
- Supportive Care
- Keywords
- Acquired brain injury, Malignant brain tumor, Relatives, Caregiver Burden, Involvement, Communication, Care transitions, Rehabilitation, Implementation, Stepped-care
- Medical subject headings
- Brain Injuries, Neurologic Manifestations, Neoplasms, Brain Injuries, Traumatic, Glioblastoma, Stroke, Brain Neoplasms, Caregiver Burden
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Supportive CareOther
The intervention uses a stepped-care model to support relatives based on their level of burden and support needs. All participants receive basic support, and additional support is offered step-by-step when needed.
Step 1 - Usual Care and Screening All relatives receive usual care and basic information. Caregiver burden is screened using the 4-item Zarit Burden Interview (ZBI-4).
Step 2 - Structured Support Relatives who screen positive on the ZBI-4 are offered a structured PIRe conversation with a nurse. The conversation focuses on the relative's role, needs, and wishes for involvement, as well as providing better overview of the care pathway.
Step 3 - Extended Support Relatives with increased burden, based on ZBI-4 results and clinical assessment, receive extended and more targeted support, including follow-up conversations and improved coordination between hospital and community services.
Step 4 - Specialized Support Relatives with high burden or complex needs receive specialized sup
| Study group | Role | What they receive |
|---|---|---|
| PIRe Stepped-Care Intervention | Experimental | Participants receive the PIRe intervention delivered within a stepped-care model targeting primary relatives of patients with acquired brain injury (ABI) or malignant brain tumor (MBT). All receive usual care (information and initial screening using Zarit-4). Based on screening and clinical assessment, support is escalated: Step 2 includes a structured PIRe conversation and needs assessment; Step 3 involves extended support and cross-sectoral coordination; Step 4 provides specialized interventions (e.g., neuropsychological support). The model enables tailored, progressive support according to caregiver burden. Receives: Other: Supportive Care |
| Usual Care | No intervention | Participants receive standard care corresponding to Step 1 of the stepped-care model, including general information and no structured PIRe intervention or systematic escalation of support. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Caregiver Burden Scale
The Caregiver Burden Scale (CBS) is used to assess the level of burden experienced by caregivers. Items are rated on a scale from 1 to 4, and mean scores are calculated across items. Higher scores indicate a higher level of perceived caregiver burden (i.e., worse outcome).
Measured: The outcome is reported as the change in caregiver burden from baseline to 3-6 months after the intervention.
Secondary outcomes (3)
Caregiver Roles and Responsibilities Scale (CRRS)
The Caregiver Roles and Responsibilities Scale (CRRS) assesses caregiver roles, responsibilities, and caregiver-related quality of life. The version used in this study comprises 41 core items (reduced version) formatted according to the Functional Assessment of Chronic Illness Therapy (FACIT) measurement system, with a 5-point Likert response scale ranging from 0 ("Not at all") to 4 ("Very much"), referring to the past 7 days.
Negatively worded items are reverse scored, and item scores are summed to a total score. The total score ranges from 0 to 164. Higher scores indicate better caregiver-related quality of life (i.e., better outcome / lower burden).
Measured: Outcomes are assessed at baseline, at transition from hospital to community care, and at 3-6 months after the intervention.
Involvement in Care - Family Perceived Support Questionnaire
The Involvement in Care - Family Perceived Support Questionnaire (ICE-FPSQ) assesses perceived support and involvement of relatives in patient care. The questionnaire consists of 14 items rated on a 5-point Likert-type scale ranging from 1 ("almost never") to 5 ("almost always").
The total score ranges from 14 to 70, with higher scores indicating greater perceived support from healthcare staff (i.e., better outcome).
Measured: Outcomes are assessed at baseline, at transition from hospital to community care, and at 3-6 months after the intervention.
Generalized Anxiety Disorder-7
The Generalized Anxiety Disorder 7-item scale (GAD-7) is used to assess symptoms of anxiety. The total score ranges from 0 to 21, with higher scores indicating more severe anxiety symptoms (i.e., worse outcome).
Measured: Outcomes are assessed at baseline, at transition from hospital to community care, and at 3-6 months after the intervention.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 May 2026
- Study start1 Oct 2026 (estimated)
- Primary completion1 Apr 2027 (estimated)
- Study completion30 Sep 2029 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (6)Papers the sponsor has linked to this study.
- Other trials for Brain Injuries, AcuteStudies of the same condition, open and under way.
- More trials run by Copenhagen University Hospital, RigshospitaletThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Non-randomised
- Intervention model
- Sequential
- Model description
- Intervention Model Description The intervention uses a stepped-care model to support relatives based on their level of burden and support needs. All participants receive basic support, and additional support is offered step-by-step when needed. Step 1 - Usual Care and Screening All relatives receive usual care and basic information. Caregiver burden is screened using the 4-item Zarit Burden Interview (ZBI-4). Step 2 - Structured Support Relatives who screen positive on the ZBI-4 are offered a structured PIRe conversation with a nurse. The conversation focuses on the relative's role, needs, and wishes for involvement, as well as providing better overview of the care pathway. Step 3 - Extended Support Relatives with increased burden, based on ZBI-4 results and clinical assessment, receive extended and more targeted support, including follow-up conversations and improved coordination between hospital and community services. Step 4 - Specialized Support Relatives with high burden or comple
- Masking
- None (open label)
- Enrolment
- 160 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Copenhagen University Hospital, Rigshospitalet
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Rikke Guldager, Copenhagen University Hospital, Rigshospitalet
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07590726
- Sponsor's protocol ID
- P2020-547
- Acronym
- PIRe
- Status last verified
- May 2026
- First submitted
- 1 May 2026
- Last updated
- 19 May 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Publications
Guldager R, Gyldenohr E, Poulsen I, Aadal L, Nordentoft S, Loft MI. Relatives' Involvement in the Care Pathway of Patients With Acquired Brain Injury or Malignant Brain Tumour: An Observational Study. Nurs Res Pract. 2026 Apr 19;2026:2280006. doi: 10.1155/nrp/2280006. eCollection 2026.
PubMed 42016768Guldager R, Sejr Smedegaard P, Nordentoft S, Aadal L, Ingerslev Loft M, Poulsen I. Facilitators and Barriers of Relatives' Involvement in Care of Patients With Acquired Brain Injury or Malignant Brain Tumour: Scoping Review. Nurs Open. 2026 Jan;13(1):e70417. doi: 10.1002/nop2.70417.
PubMed 41559742Lundh MG, Nordentoft S, Smedegaard PS, Aadal L, Loft MI, Poulsen I, Guldager R. Interventions facilitating the involvement of relatives of patients with acquired brain injury or malignant brain tumour: A scoping review. J Clin Nurs. 2025 Mar;34(3):784-794. doi: 10.1111/jocn.17328. Epub 2024 Jul 30.
PubMed 39078079Guldager R, Nordentoft S, Poulsen I, Aadal L, Loft MI. Wants and needs for involvement reported by relatives of patients with a malignant brain tumor: a scoping review. JBI Evid Synth. 2023 Nov 1;21(11):2188-2210. doi: 10.11124/JBIES-22-00311.
PubMed 37435678Guldager R, Nordentoft S, Poulsen I, Aadal L, Loft MI. Wants and needs for involvement experienced by relatives of patients with an acquired brain injury: a scoping review. JBI Evid Synth. 2023 May 1;21(5):886-912. doi: 10.11124/JBIES-22-00022.
PubMed 36729839Guldager R, Nordentoft S, Aadal L, Loft MI, Poulsen I. Wants and needs of relatives' involvement in patient care: the same but different. JBI Evid Synth. 2023 Nov 1;21(11):2154-2155. doi: 10.11124/JBIES-23-00469. No abstract available.
PubMed 37935421
Study at a glance
From the registry record, last updated by the sponsor on 19 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- PIRe 2.0: A Stepped-Care Model for Involving Relatives Across Sectors
- ClinicalTrials.gov ID
- NCT07590726
- Acronym / sponsor ID
- PIRe / P2020-547
- Conditions
- Brain Injuries, Acute, Brain Tumor Adult, Brain (Nervous System) Cancers, Traumatic Brain Injuries, Glioblastom WHO Grade 4, Glioblastoma (GBM)
- Keywords
- Acquired brain injury, Malignant brain tumor, Relatives, Caregiver Burden, Involvement, Communication, Care transitions, Rehabilitation
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 160 participants (estimated)
- Lead sponsor
- Copenhagen University Hospital, RigshospitaletUniversity, hospital or other
- Study start
- 1 Oct 2026 (estimated)
- Primary completion
- 1 Apr 2027 (estimated)
- Study completion
- 30 Sep 2029 (estimated)
- First posted
- 15 May 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Serious brain diseases and injuries affect not only the person who becomes ill or injured, but also their family. Relatives of people with acquired brain injury (ABI) or malignant brain tumor (MBT) often take on a major role in daily care, decision-making, and coordination across healthcare services. This role can include managing information, supporting rehabilitation, and acting as a link between hospital care and community rehabilitation. Many relatives report high levels of stress, uncertainty, and emotional burden, especially during transitions between care settings.
Despite recommendations for greater involvement of relatives, support for this group is often uneven and poorly coordinated across healthcare sectors. Relatives frequently experience lack of overview, limited guidance, and unclear expectations regarding their role. These challenges may increase caregiver burden and negatively affect both relatives' well-being and the continuity of care.
The PIRe 2.0 study aims to further test, and implement a structured intervention to support systematic involvement of relatives of people with ABI or MBT across hospital and community rehabilitation services. The intervention is designed as a "caregiver compass" that helps relatives understand their role, clarify their needs and wishes for involvement, and gain better overview of the care pathway.
PIRe 2.0 is delivered through a stepped-care model, which allows the level of support to be adjusted over time based on each relative's level of burden and support needs. All relatives receive basic information and screening for caregiver burden using the 4-item Zarit Burden Interview (ZBI-4). Relatives who show signs of increased burden are offered additional support in steps, ranging from structured conversations with nurses to extended cross-sector coordination and specialized support for relatives with high or complex needs. Decisions about stepping up or down are based on both screening results and clinical assessment to ensure flexibility and person-centered care.
The study includes two groups of relatives: an intervention group receiving support through the PIRe stepped-care model, and a control group receiving usual care only. A total of 160 relatives will participate. Data are collected at baseline, at transitions between hospital and community care, and three to six months after the intervention.
The primary outcome is change in caregiver burden, measured with the Caregiver Burden Scale (CBS). Secondary outcomes include relatives' roles and responsibilities, perceived support and involvement in care, and mental well-being, assessed using validated patient-reported outcome measures.
In addition to evaluating the effect of the intervention, the study examines how the PIRe model can be implemented and sustained in everyday practice across healthcare sectors. The results are expected to show whether a structured, stepped-care approach can reduce caregiver burden, improve coordination between hospital and community services, and support more coherent and secure care pathways for people with ABI or malignant brain tumor and their relatives.
Detailed description
Relatives of people with acquired brain injury (ABI) or malignant brain tumor (MBT, World Health Organization grade 3-4) play a central role in supporting patients throughout complex neurological care pathways. Both patient groups are characterized by multifaceted disease trajectories and substantial needs for coordination and support within the healthcare system. These demands are often associated with high caregiver burden among relatives. While ABI trajectories typically involve prolonged rehabilitation and long-term functional impairments, MBT is more often characterized by an acute, progressive, and life-threatening course. Despite these differences, relatives across both groups face considerable emotional, practical, and organizational challenges.
Even within well-developed healthcare systems, relatives continue to perform a large share of care and coordination tasks and frequently assume an informal caregiver role without sufficient professional support or clear coordination across sectors. This role is associated with increased risk of emotional distress, frustration, and reduced mental well-being. Although policies and guidelines recommend greater involvement of relatives, systematic and structured approaches to supporting relatives in clinical practice remain limited.
Transitions between hospital care and community-based rehabilitation represent a particularly vulnerable phase. Insufficient communication and lack of continuity across sectors are well-documented sources of burden for relatives. Studies show that breakdowns in communication during transitions increase the risk of uncertainty, misunderstandings, and experiences of exclusion. Relatives often describe acting as informal coordinators and intermediaries between healthcare sectors, a role that may substantially increase both practical and emotional strain, especially when expectations and responsibilities are unclear.
To address these challenges, the PIRe intervention was developed as a nurse-led, multicomponent approach aimed at strengthening early and meaningful involvement of relatives. The intervention combines structured conversations with relatives, diagnosis-specific information delivered in an accessible format (including digital access), and a peer-developed checklist to support navigation of the care pathway. Findings from a prior feasibility study demonstrated substantial variation in relatives' needs over time. Many relatives in the acute phase had limited capacity for intensive support, while the need for more targeted and sustained support often increased later in the disease trajectory. These findings highlighted the need for a systematic yet flexible organizational framework that can tailor support over time and ensure continuity across hospital and community settings.
A stepped-care approach provides an evidence-based framework for structuring support and involvement of relatives with the possibility of gradual escalation and de-escalation across sectors. PIRe 2.0 represents the next step as a real-world effectiveness and implementation study in which the PIRe intervention is delivered and evaluated as a scalable stepped-care model for systematic involvement of relatives in complex neurological care pathways.
The overall aim of the PIRe 2.0 study is to evaluate the effect of the PIRe intervention on caregiver burden among relatives of people with ABI or MBT when delivered through a stepped-care model. In parallel, the study aims to evaluate key implementation outcomes when the intervention is delivered across hospital departments and community rehabilitation services.
Design and Study Components PIRe 2.0 comprises two concurrent and complementary sub-studies. Both involve delivery of the PIRe intervention but serve different analytical purposes. Sub-study 1 evaluates the effectiveness of the intervention under real-world conditions, while Sub-study 2 focuses on the development, evaluation, and refinement of an implementation strategy and examines organizational embedding in hospital and municipal practice.
Stepped-Care Framework The stepped-care model constitutes the shared structural framework for both the effectiveness and implementation components. The model is centered on systematic screening and monitoring of caregiver burden using the 4-item Zarit Burden Interview (ZBI-4), a validated tool for identifying caregiver-related strain. Screening results, combined with clinical assessment, guide decisions regarding the appropriate level of support within the model.
ZBI-4 is applied across all steps of the model as both a screening and monitoring tool. Initial screening is conducted at the start of hospital admission, with repeated assessments during hospitalization, at sector transitions, and when clinical concern about changes in caregiver burden arises. Guideline-based threshold values are used to support decisions about escalating or de-escalating support while maintaining flexibility through clinical judgment. This approach is intended to ensure individualized and responsive care for relatives.
Recruitment and Study Population Relatives are recruited through convenience sampling from participating neurological, neurosurgical, and neurorehabilitation departments at collaborating hospitals. A total of 160 relatives are included, divided between an intervention group and a control group receiving usual care. A sequential inclusion design is used, where the control group is fully recruited and completed prior to initiation of the intervention group. This design minimizes risk of contamination and ensures that staff training and intervention implementation are completed before delivery of the intervention.
Data Collection and Analysis Data are collected at baseline, at transitions between hospital and community rehabilitation, and three to six months after intervention delivery. The study uses validated patient-reported outcome instruments to assess caregiver burden, roles and responsibilities, perceived support and involvement, and mental well-being. Electronic data collection is used throughout, with secure data management procedures in place.
Intervention effects are analyzed using linear mixed-effects regression models, allowing for evaluation of changes over time and accounting for repeated measurements. The primary outcome is change in caregiver burden, with secondary outcomes addressing functional roles, perceived support, and symptoms of anxiety and depression.
Implementation Evaluation The implementation component of PIRe 2.0 is guided by theory- and evidence-based frameworks and informed by experiences from the prior feasibility study. The implementation strategy is developed in close collaboration with clinical and municipal stakeholders and evaluated across multiple dimensions, including acceptability, appropriateness, feasibility, fidelity, penetration, and sustainability. The sequential study design facilitates stepwise testing and refinement of the implementation strategy prior to full-scale rollout in routine practice.
The implementation targets nurses in hospital departments and community rehabilitation services who are involved in care trajectories for patients with ABI or MBT and their relatives. Training, standardized manuals, and ongoing supervision are used to support consistent and high-quality delivery of the intervention.
Cross-Sector Collaboration and Context The study is anchored in close cross-sector collaboration between hospitals and municipal rehabilitation services and is conducted in both urban and rural settings. This allows evaluation of the intervention under varying organizational conditions and strengthens the generalizability of findings. The study is conducted during a period of significant structural healthcare reforms, requiring a high degree of flexibility to adapt to changing organizational contexts.
User and Public Involvement Relatives of people with ABI and MBT are involved through an advisory panel that contributes to refining intervention content, relevance, and interpretation of results. User involvement is documented systematically and embedded throughout the project to ensure alignment with relatives' needs and perspectives.
Ethics and Expected Impact The study is conducted in accordance with ethical principles and data protection regulations. Participation is voluntary, and data are handled confidentially.
PIRe 2.0 addresses a well-documented need for more systematic and coordinated involvement of relatives in complex neurological care pathways. By combining a stepped-care model with cross-sector collaboration, the study aims to reduce caregiver burden, strengthen continuity of care, and support sustainable implementation of a scalable model that can be integrated into routine clinical and municipal practice and adapted to other patient groups.
Study design
- Primary purpose
- Supportive care
- Allocation
- Non-randomised
- Intervention model
- Sequential
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Intervention Model Description The intervention uses a stepped-care model to support relatives based on their level of burden and support needs. All participants receive basic support, and additional support is offered step-by-step when needed. Step 1 - Usual Care and Screening All relatives receive usual care and basic information. Caregiver burden is screened using the 4-item Zarit Burden Interview (ZBI-4). Step 2 - Structured Support Relatives who screen positive on the ZBI-4 are offered a structured PIRe conversation with a nurse. The conversation focuses on the relative's role, needs, and wishes for involvement, as well as providing better overview of the care pathway. Step 3 - Extended Support Relatives with increased burden, based on ZBI-4 results and clinical assessment, receive extended and more targeted support, including follow-up conversations and improved coordination between hospital and community services. Step 4 - Specialized Support Relatives with high burden or comple
| Arm | Type | Receives |
|---|---|---|
| PIRe Stepped-Care Intervention | Experimental | Other: Supportive CareParticipants receive the PIRe intervention delivered within a stepped-care model targeting primary relatives of patients with acquired brain injury (ABI) or malignant brain tumor (MBT). All receive usual care (information and initial screening using Zarit-4). Based on screening and clinical assessment, support is escalated: Step 2 includes a structured PIRe conversation and needs assessment; Step 3 involves extended support and cross-sectoral coordination; Step 4 provides specialized interventions (e.g., neuropsychological support). The model enables tailored, progressive support according to caregiver burden. |
| Usual Care | No intervention | –Participants receive standard care corresponding to Step 1 of the stepped-care model, including general information and no structured PIRe intervention or systematic escalation of support. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Primary relative of an adult diagnosed with acquired brain injury (ABI) or malignant brain tumor (MBT), admitted to a participating hospital department.
- Formally identified as the primary relative by the patient.
- Aged ≥18 years.
- Ability to read, understand, and complete questionnaires in Danish.
Key exclusion criteria (2 listed)
- Insufficient proficiency in Danish to complete questionnaires and participate in structured conversations.
- Concurrent participation in another interventional study with a similar aim that may interfere with the present study.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Supportive CareThe intervention uses a stepped-care model to support relatives based on their level of burden and support needs. All participants receive basic support, and additional support is offered step-by-step when needed. Step 1 - Usual Care and Screening All relatives receive usual care and basic information. Caregiver burden is screened using the 4-item Zarit Burden Interview (ZBI-4). Step 2 - Structured Support Relatives who screen positive on the ZBI-4 are offered a structured PIRe conversation with a nurse. The conversation focuses on the relative's role, needs, and wishes for involvement, as well as providing better overview of the care pathway. Step 3 - Extended Support Relatives with increased burden, based on ZBI-4 results and clinical assessment, receive extended and more targeted support, including follow-up conversations and improved coordination between hospital and community services. Step 4 - Specialized Support Relatives with high burden or complex needs receive specialized sup | Other | PIRe Stepped-Care Intervention |
Primary outcome
Caregiver Burden Scale
Time frame: The outcome is reported as the change in caregiver burden from baseline to 3-6 months after the intervention.
The Caregiver Burden Scale (CBS) is used to assess the level of burden experienced by caregivers. Items are rated on a scale from 1 to 4, and mean scores are calculated across items. Higher scores indicate a higher level of perceived caregiver burden (i.e., worse outcome).
3 secondary outcomes
Caregiver Roles and Responsibilities Scale (CRRS)
Time frame: Outcomes are assessed at baseline, at transition from hospital to community care, and at 3-6 months after the intervention.
Involvement in Care - Family Perceived Support Questionnaire
Time frame: Outcomes are assessed at baseline, at transition from hospital to community care, and at 3-6 months after the intervention.
Generalized Anxiety Disorder-7
Time frame: Outcomes are assessed at baseline, at transition from hospital to community care, and at 3-6 months after the intervention.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 May 2026.
- Background: PubMed 42016768Guldager R, Gyldenohr E, Poulsen I, Aadal L, Nordentoft S, Loft MI. Relatives' Involvement in the Care Pathway of Patients With Acquired Brain Injury or Malignant Brain Tumour: An Observational Study. Nurs Res Pract. 2026 Apr 19;2026:2280006. doi: 10.1155/nrp/2280006. eCollection 2026.
- Background: PubMed 41559742Guldager R, Sejr Smedegaard P, Nordentoft S, Aadal L, Ingerslev Loft M, Poulsen I. Facilitators and Barriers of Relatives' Involvement in Care of Patients With Acquired Brain Injury or Malignant Brain Tumour: Scoping Review. Nurs Open. 2026 Jan;13(1):e70417. doi: 10.1002/nop2.70417.
- Background: PubMed 39078079Lundh MG, Nordentoft S, Smedegaard PS, Aadal L, Loft MI, Poulsen I, Guldager R. Interventions facilitating the involvement of relatives of patients with acquired brain injury or malignant brain tumour: A scoping review. J Clin Nurs. 2025 Mar;34(3):784-794. doi: 10.1111/jocn.17328. Epub 2024 Jul 30.
- Background: PubMed 37435678Guldager R, Nordentoft S, Poulsen I, Aadal L, Loft MI. Wants and needs for involvement reported by relatives of patients with a malignant brain tumor: a scoping review. JBI Evid Synth. 2023 Nov 1;21(11):2188-2210. doi: 10.11124/JBIES-22-00311.
- Background: PubMed 36729839Guldager R, Nordentoft S, Poulsen I, Aadal L, Loft MI. Wants and needs for involvement experienced by relatives of patients with an acquired brain injury: a scoping review. JBI Evid Synth. 2023 May 1;21(5):886-912. doi: 10.11124/JBIES-22-00022.
- Background: PubMed 37935421Guldager R, Nordentoft S, Aadal L, Loft MI, Poulsen I. Wants and needs of relatives' involvement in patient care: the same but different. JBI Evid Synth. 2023 Nov 1;21(11):2154-2155. doi: 10.11124/JBIES-23-00469. No abstract available.
- Individual participant dataSharing planned: Undecided
Related trials for Brain Injuries, Acute
RecruitingObservational study
Sleep to Predict Recovery In Unconscious Patients With Acute Brain Injury
Traumatic Brain Injury (TBI) Patients, Intracerebral Hemorrhage (ICH)
Recruiting
The Coma Family Program (COMA-F): A Resilience Program for Caregivers of Patients With Severe Acute Brain Injury
Caregiver Distress, Emotional Distress
Recruiting
Rapid Local Ischemic Postconditioning on Stroke After Thrombectomy
Acute Ischemic Stroke
Enrolling by invitation
Fareon Open Label Device Clinical Trial
Cognitive Dysfunction, Acquired Brain Injury
Not yet recruiting
Supplementary Neuromuscular Rehabilitation During Acute Concussion Recovery
Concussion (Diagnosis), Gait Abnormality
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Supportive Care in people with Brain Injuries, Acute and Brain Tumor Adult, run by Copenhagen University Hospital, Rigshospitalet at 1 site in Denmark.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 19 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Rikke Guldager, PhD (0045 51199727, rikke.guldager.01@regionh.dk), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Caregiver Burden Scale (time frame: The outcome is reported as the change in caregiver burden from baseline to 3-6 months after the intervention.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07590726, which also lists 6 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 May 2026.